参考文献/References:
[1] Kang JS,Moon KH,Kwon DG,et al.The natural history of asymptomatic osteonecrosis of the femoral head[J].Int Orthop,2013,37(3):379-384.
[2] 李子荣.股骨头骨坏死的ARCO分期[J].中华外科杂志,1996,34(3):186-187.
[3] Mont MA,Hungerford DS.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[4] 陈卫衡,刘道兵,张洪美,等.股骨头坏死的三期四型辨证思路[J].中国中医基础医学杂志,2003,9(12):51-52.
[5] 陈卫衡,周宇,何海军,等.健脾活骨方治疗早中期非创伤性股骨头坏死的前瞻性临床研究[J].中华关节外科杂志:电子版,2013,7(3):287-293.
[6] 李晓明,郭东辉,石国君,等.髓芯减压联合丹参酮ⅡA混合植骨治疗FicatⅡ期股骨头坏死[J].中医正骨,2014,26(5):9-12.
[7] 陈卫衡,谢斌,刘道兵,等.髓芯减压植骨术治疗股骨头坏死临床疗效的动态研究[J].中华关节外科杂志:电子版,2014(5):578-584.
[8] Gao YS,Chen SB,Jin DX,et al.Modified surgical techniques of free vascularized fibular grafting for treatment of the osteonecrosis of femoral head:results from a series of 407 cases[J].Microsurgery,2013,33(8):646-651.
[9] Ali SA,Christy JM,Griesser MJ,et al.Treatment of avascular necrosis of the femoral head utilising free vascularised fibular graft:a systematic review[J].Hip Int,2014,24(1):5-13.
[10] 中华医学会骨科分会显微修复学组.成人股骨头坏死诊疗标准专家共识(2012年版)[J].中华骨科杂志,2012,32(6):185-192.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]唐立明,庞智晖,樊粤光,等.“辨稳论治”微观辨证理念指导下的股骨头坏死围塌陷期分型及其临床应用价值[J].中医正骨,2016,28(05):63.
[11]姚晨,沈计荣,杜斌,等.口服补肾活血汤联合微创保髋术治疗股骨头坏死肾虚血瘀证的临床研究[J].中医正骨,2016,28(11):7.
YAO Chen,SHEN Jirong,DU Bin,et al.Clinical study on oral application of Bushen Huoxue Tang(补肾活血汤)combined with minimally invasive hip-preserving surgery for treatment of kidney-deficiency-blood-stasis-type osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):7.
[12]夏天卫,李若颀,环大维,等.基于网络药理学方法探究补肾活血汤治疗激素性股骨头坏死的作用机制[J].中医正骨,2020,32(03):14.
XIA Tianwei,LI Ruoqi,HUAN Dawei,et al.A study of mechanism of action of Bushen Huoxue Tang(补肾活血汤)for treatment of steroid-induced osteonecrosis of the femoral head using network pharmacology approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(03):14.
[13]范奕松,俞桂松,唐振坤,等.补肾活血汤治疗股骨头坏死的系统评价[J].中医正骨,2020,32(03):26.
FAN Yisong,YU Guisong,TANG Zhenkun,et al.Systematic review on Bushen Huoxue Tang(补肾活血汤)for treatment of osteonecrosis of the femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(03):26.